After an incorrect risk assessment by the Danish National Food Administration regarding the safety of ashwagandha root - where, based on mainly small animal studies on leaves and stems, they incorrectly concluded that ashwagandha root can have negative effects, we have chosen to publish a complete safety assessment of KSM66. The most used and clinically studied ashwagandha in the world.
For more information, contact Tom Johnsson, head of R&D: +46705949195, tom@medicinegarden.se
Download:
-> KSM66_Safety_Studies_March 2024_English.pdf
-> Appendix 1_SAFETY EVALUATION_ROOT PART VS. AERIAL PARTS.pdf
-> Appendix 2_Safety Opinion of Standardized Ashwagandha Root Extract.pdf
